摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-{[(2E)-3-甲基-4-(4-甲基-5-氧代-2,5-二氢-2-呋喃基)-2-丁烯-1-基]氧基}-7H-呋喃并[3,2-g]苯并吡喃-7-酮 | 87838-97-9

中文名称
9-{[(2E)-3-甲基-4-(4-甲基-5-氧代-2,5-二氢-2-呋喃基)-2-丁烯-1-基]氧基}-7H-呋喃并[3,2-g]苯并吡喃-7-酮
中文别名
山梨聚糖,三辛酸酯
英文名称
indicolactone
英文别名
Clausenacoumarine;9-[(E)-3-methyl-4-(4-methyl-5-oxo-2H-furan-2-yl)but-2-enoxy]furo[3,2-g]chromen-7-one
9-{[(2E)-3-甲基-4-(4-甲基-5-氧代-2,5-二氢-2-呋喃基)-2-丁烯-1-基]氧基}-7H-呋喃并[3,2-g]苯并吡喃-7-酮化学式
CAS
87838-97-9
化学式
C21H18O6
mdl
——
分子量
366.37
InChiKey
XVVBVBKVMMNZHB-LFYBBSHMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    612.6±55.0 °C(Predicted)
  • 密度:
    1.303±0.06 g/cm3(Predicted)
  • LogP:
    1.597 (est)

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    27
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    75
  • 氢给体数:
    0
  • 氢受体数:
    6

SDS

SDS:84d1631a312d23eaf3c787cf25f2ee8c
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • FURANOCOUMARINS FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES
    申请人:Leeward Pacific Pte Ltd
    公开号:EP3389649B1
    公开(公告)日:2020-10-21
  • COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES
    申请人:LEEWARD PACIFIC PTE LTD
    公开号:US20190046503A1
    公开(公告)日:2019-02-14
    The present invention provides a compound belonging to furanocoumarin derivative having core structure (A) as given below, its pharmaceutically acceptable salt, isomer or a combination thereof for the treatment and/or prevention of a parasitic mediated disease. The present invention also provides a method for manufacturing and isolating said compound as well as method for treatment and prevention of parasitic mediated disease using said compound. In a preferred embodiment, the parasite is Plasmodium falciparum , the disease mediated by the said parasite is malaria and the furanocoumarin derivative having core structure (A) is Anisolactone.
  • [EN] COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES<br/>[FR] COMPOSÉ POUR UNE UTILISATION DANS LE TRAITEMENT ET/OU LA PRÉVENTION DE MALADIES D'ORIGINE PARASITAIRE
    申请人:LEEWARD PACIFIC PTE LTD
    公开号:WO2017155465A1
    公开(公告)日:2017-09-14
    The present invention provides a compound belonging to furanocoumarin derivative having core structure (A) as given below, its pharmaceutically acceptable salt, isomer or a combination thereof for the treatment and/or prevention of a parasitic mediated disease. The present invention also provides a method for manufacturing and isolating said compound as well as method for treatment and prevention of parasitic mediated disease using said compound. In a preferred embodiment, the parasite is Plasmodium falciparum, the disease mediated by the said parasite is malaria and the furanocoumarin derivative having core structure (A) is Anisolactone.
  • Monoterpenoid furanocoumarin lactones from clausena anisata
    作者:Vijai Lakshmi、Dhan Prakash、Kanwal Raj、Randhir S. Kapil、Satya P. Popli
    DOI:10.1016/s0031-9422(00)84114-x
    日期:1984.1
    Abstract A reinvestigation of Clausena anisata has yielded imperatorin, xanthotoxol, lansamide-I and three new furanocoumarin lactone derivatives: indicolactone, anisolactone and 2′,3′-epoxyanisolactone. The structures of these compounds have been elucidated by a combination of spectroscopic and chemical methods.
    摘要 对茴香花的再研究产生了欧前胡素、黄酮醇、兰沙酰胺-I 和三种新的呋喃香豆素内酯衍生物:茚内酯、茴香内酯和 2',3'-环氧茴香内酯。这些化合物的结构已通过光谱和化学方法的组合阐明。
查看更多